CIRM-funded Clinical Trial Aimed at Blocking HIV/AIDS in People Gets the Go Ahead

An innovative therapy using a patient's own stem cells, modified to resist infection with the AIDS virus, has been given approval by the Food and Drug Administration to begin a clinical trial in people. CIRM, California's stem cell agency, is funding that trial.

http://ift.tt/18jybKQ